Medinotec (MDNC) Capital Expenditures (2022 - 2026)
Medinotec (MDNC) posted Capital Expenditures of $40350.0 for Q2 2026, up 3097.77% on a QoQ basis from -$1346.0 in Q1 2025.
Medinotec (MDNC) Capital Expenditures (2022 - 2026) Analysis & Trends
Medinotec's Capital Expenditures history runs 5 years deep, the most recent figure standing at $40350.0 for Q2 2026.
- Quarterly Capital Expenditures changed N/A year-over-year to $40350.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was $135418.0 (changed N/A YoY) and the FY2026 annual result came in at $1363.0, down 98.47% from the prior year.
- Capital Expenditures was $40350.0 for Q2 2026 at Medinotec, up from -$1346.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $86602.0 in Q4 2022 and bottomed at -$90556.0 in Q1 2022.
- A 5-year average of $8425.5 and a median of -$1404.0 in 2024 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2023 — Capital Expenditures soared 98.05% — and 2025, when it gained 4.13%.
- Medinotec's Capital Expenditures stood at $86602.0 in 2022, then plunged by 102.04% to -$1765.0 in 2023, then soared by 4214.79% to $72626.0 in 2024, then plunged by 101.85% to -$1346.0 in 2025, then surged by 3097.77% to $40350.0 in 2026.
- Business Quant data shows MDNC's Capital Expenditures at $40350.0 in Q2 2026, -$1346.0 in Q1 2025, and $72626.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | 40,350.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 40,350.00 |
| May 31, 2026 | 40,350.00 |
| Feb 28, 2025 | -1,346.00 |
| Feb 28, 2025 | -1,346.00 |
| Nov 30, 2024 | 72,626.00 |
| Nov 30, 2024 | 72,626.00 |
| Aug 31, 2024 | 23,788.00 |
| Aug 31, 2024 | 23,788.00 |
| May 31, 2024 | -6,055.00 |
| May 31, 2024 | -6,055.00 |
| Feb 29, 2024 | -1,404.00 |
| Feb 29, 2024 | -1,404.00 |
| Feb 28, 2023 | -1,765.00 |
| Feb 28, 2023 | -1,765.00 |
| Nov 30, 2022 | 86,602.00 |
| Nov 30, 2022 | 86,602.00 |
| Aug 31, 2022 | -9,467.00 |
| Aug 31, 2022 | -9,467.00 |
| May 31, 2022 | -20,093.00 |
| May 31, 2022 | -20,093.00 |